title: Alternative treatment for systemic involvement in a child with postdiarrheal hemolytic-uremic syndrome.
authors.forename: E
authors.initials: E
authors.lastname: Oki
authors.forename: K
authors.initials: K
authors.lastname: Tsuruga
authors.forename: K
authors.initials: K
authors.lastname: Tsugawa
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Shinagawa
authors.forename: T
authors.initials: T
authors.lastname: Nakahata
authors.forename: E
authors.initials: E
authors.lastname: Ito
authors.forename: H
authors.initials: H
authors.lastname: Tanaka
mesh_terms: D002648:Child; D003131:Combined Modality Therapy; D016207:Cytokines / Q000097:blood; D003967:Diarrhea / Q000382:microbiology; D005938:Glucocorticoids / Q000627:therapeutic use; D017583:Hemodiafiltration; D006463:Hemolytic-Uremic Syndrome / Q000097:blood / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D016207:Cytokines; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone